Finally, CPVT4-ANK2 mutations [11] and CPVT5-KCNJ2 mutations [12] were seen in a minority of CPVT patients (<1%), in an autosomal dominant manner with an M/F ratio of 1:1. This evidence concerns the gene ANK2 and catecholaminergic polymorphic ventricular tachycardia.